NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
23 October 2024
| Name: | PROBIOMICS LIMITED (PCC) (This company subsequently changed its name to BIOXYNE LIMITED. You should refer to that name for Status.) | ||||||
| Date of Listing: | 14 December 2000 | ||||||
| Subsequent Names: |
| ||||||
| Former Names: |
|
Stock Exchange Status: (updated daily)
This company subsequently changed its name to BIOXYNE LIMITED. You should refer to that name for Stock Exchange Status.Legal Status: (updated monthly)
This company subsequently changed its name to BIOXYNE LIMITED. You should refer to that name for Legal Status.Capital Gains Tax (CGT) Status: (updated at least quarterly)
This company subsequently changed its name and is now BIOXYNE LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| BIOXYNE LIMITED | 10/04/2012 | |
| PROBIOMICS LIMITED | 02/05/2005 | 10/04/2012 |
| VRI BIOMEDICAL LIMITED | 02/05/2005 |
Computershare Sydney
6 Hope St Ermington NSW 2115
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 2 8235 8150
RegistryWebsite RegistryEmail
Expand this box to read and print
name changed to Bioxyne Limited | 10/04/2012 |
The suspension of trading in the securities of Probiomics Limited will be lifted from the commencement of trading on Wednesday, 4 April 2012 following re-compliance with Chapters 1 and 2 of the ASX Listing Rules | 03/04/2012 |
we understand that on or about this date the company consolidated its shares 1 for 20 | 29/03/2012 |
Probiomics ("Company", ASX: PCC) expects that the re-admission of the Company to the ASX Official List, and the re-commencement of trading in the Company" securities on ASX will occur on 4 April, 2012 | 15/03/2012 |
Probiomics Limited ("Company" ASX Code:PCC) advised in its announcement dated 3 February, 2012 that the proposed 1:20 share consolidation would occur on 21 March, 2012. The Company advises that the occurrence of that share consolidation will be slightly delayed and that the Company will be shortly publishing an amended timetable | 14/03/2012 |
Probiomics Limited (ASX: PCC) (Probiomics) announces that the minimum subscription of $2.2 million under the Public Offer has been achieved | 02/03/2012 |
Half Yearly Report And Accounts released | 01/03/2012 |
The securities of Probiomics Limited (the "Company") will be suspended from quotation immediately, following shareholder approval of resolutions at the Company" general meeting regarding the takeover of Hunter Immunology Limited. | 07/02/2012 |
the suspension of trading in the securities of Probiomics Limited (the "Company") will be lifted immediately following receipt of an announcement regarding the Company's proposed merger with Hunter Immunology Limited | 12/10/2011 |
the securities of Probiomics Limited (the "Company") will be suspended from quotation immediately, following the announcement of the Company's proposed merger with Hunter Immunology Limited | 11/10/2011 |
securities reinstated to quotation | 04/03/2008 |
securities suspended from quotation following failure to lodge its half report for the period ended 31 December 2007 | 03/03/2008 |
name changed from VRI Biomedical Limited | 02/05/2005 |
name changed to Bioxyne Limited | 10/04/2012 |
The suspension of trading in the securities of Probiomics Limited will be lifted from the commencement of trading on Wednesday, 4 April 2012 following re-compliance with Chapters 1 and 2 of the ASX Listing Rules | 03/04/2012 |
we understand that on or about this date the company consolidated its shares 1 for 20 | 29/03/2012 |
Probiomics ("Company", ASX: PCC) expects that the re-admission of the Company to the ASX Official List, and the re-commencement of trading in the Company" securities on ASX will occur on 4 April, 2012 | 15/03/2012 |
Probiomics Limited ("Company" ASX Code:PCC) advised in its announcement dated 3 February, 2012 that the proposed 1:20 share consolidation would occur on 21 March, 2012. The Company advises that the occurrence of that share consolidation will be slightly delayed and that the Company will be shortly publishing an amended timetable | 14/03/2012 |
Probiomics Limited (ASX: PCC) (Probiomics) announces that the minimum subscription of $2.2 million under the Public Offer has been achieved | 02/03/2012 |
Half Yearly Report And Accounts released | 01/03/2012 |
The securities of Probiomics Limited (the "Company") will be suspended from quotation immediately, following shareholder approval of resolutions at the Company" general meeting regarding the takeover of Hunter Immunology Limited. | 07/02/2012 |
the suspension of trading in the securities of Probiomics Limited (the "Company") will be lifted immediately following receipt of an announcement regarding the Company's proposed merger with Hunter Immunology Limited | 12/10/2011 |
the securities of Probiomics Limited (the "Company") will be suspended from quotation immediately, following the announcement of the Company's proposed merger with Hunter Immunology Limited | 11/10/2011 |
securities reinstated to quotation | 04/03/2008 |
securities suspended from quotation following failure to lodge its half report for the period ended 31 December 2007 | 03/03/2008 |
name changed from VRI Biomedical Limited | 02/05/2005 |
Your browser may reflect a date of printing in American format.
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Patrick Ford | Non Exec Chairman | 20/05/2005 |
| Ashok Jairath | CFO, Company Secretary | 27/07/2007 |
| Simon O'Loughlin | Non Exec Director | 31/07/2008 |
| Simon Taylor | Non Exec Director | 25/07/2008 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.